A hearing began today in an Indian court to gain clarity on the status of the country’s laws regarding the protection of intellectual property and the granting of patents, which are critical to helping patients by creating incentives for long-term R&D investments into new and better medicines. The hearing taking place in Chennai is part of efforts by Novartis...to gain a patent for its life-saving medicine Glivec.